Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A ricin-based peptide BRIP from Hordeum vulgare inhibits Mpro of SARS-CoV-2
Prakriti Kashyap, Vijay Kumar Bhardwaj, Mahima Chauhan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Inhibition of nonstructural protein 15 of SARS‐CoV‐2 by golden spice: A computational insight
Rahul Singh, Vijay Kumar Bhardwaj, Rituraj Purohit
Cell Biochemistry and Function (2022) Vol. 40, Iss. 8, pp. 926-934
Open Access | Times Cited: 71
New Dual Inhibitors of SARS-CoV-2 Based on Metal Complexes with Schiff-Base 4-Chloro-3-Methyl Phenyl Hydrazine: Synthesis, DFT, Antibacterial Properties and Molecular Docking Studies
Ahmed S. Al‐Janabi, Amin O. Elzupir, Mortaga M. Abou–Krisha, et al.
Inorganics (2023) Vol. 11, Iss. 2, pp. 63-63
Open Access | Times Cited: 19
Inhibitory Activity of Saussurea costus Extract against Bacteria, Candida, Herpes, and SARS-CoV-2
Hajo Idriss, Babeker Siddig, Pamela González-Maldonado, et al.
Plants (2023) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 15
The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review
Irma Rahayu Latarissa, Anna Meiliana, Ida Paulina Sormin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
Influence of EGCG oxidation on inhibitory activity against the SARS-CoV-2 main protease
Yufeng He, Meng Hao, Mingchuan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133451-133451
Closed Access | Times Cited: 4
Physiological Mechanisms by Which the Functional Ingredients in Beer Impact Human Health
Yawen Zeng, Hafiz Ghulam Muhu‐Din Ahmed, Xia Li, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3110-3110
Open Access | Times Cited: 4
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
Davide Gentile, Alessandro Coco, Vincenzo Patamia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10067-10067
Open Access | Times Cited: 16
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets
Tao Yang, Si Chun Wang, Linyan Ye, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 247-268
Closed Access | Times Cited: 8
In-silico study: docking simulation and molecular dynamics of peptidomimetic fullerene-based derivatives against SARS-CoV-2 Mpro
Noha A. Saleh
3 Biotech (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 8
Plant‐derived compounds as potential leads for new drug development targeting COVID‐19
Lingxiu Liu, Maxim V. Kapralov, Mark Ashton
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1522-1554
Open Access | Times Cited: 3
Actional Mechanism of Functional Ingredients in Beer and Barley for Human Health
Yawen Zeng, Hafiz Ghulam Muhu‐Din Ahmed, Xia Li, et al.
(2024)
Open Access | Times Cited: 2
Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study
Sarfraz Ahmad, Muhammad Usman Mirza, John F. Trant
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 5, pp. 523-534
Open Access | Times Cited: 4
In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2
Gaurav Kumar Sharma, Prateek Paul, Ananya Dviwedi, et al.
3 Biotech (2024) Vol. 14, Iss. 9
Closed Access | Times Cited: 1
Integrated Computational and Experimental Approaches to Identify New Papain-Like Protease Inhibitors
Rahul Singh, Amit Dhiman, Mahima Chauhan, et al.
Journal of Molecular Structure (2024), pp. 140460-140460
Closed Access | Times Cited: 1
L-shaped distribution of the relative substitution rate (c/μ) observed for SARS-COV-2's genome, inconsistent with the selectionist theory, the neutral theory and the nearly neutral theory but a near-neutral balanced selection theory: Implication on “neutralist-selectionist” debate
Chun Wu, Nicholas J. Paradis, Phillip M. Lakernick, et al.
Computers in Biology and Medicine (2023) Vol. 153, pp. 106522-106522
Open Access | Times Cited: 3
In-silico analysis of ribosome inactivating protein (RIP) of the Cucurbitaceae family
Quratulain Maqsood, Aleena Sumrin, Qurban Ali, et al.
AMB Express (2024) Vol. 14, Iss. 1
Open Access
Molecular dynamics-driven exploration of peptides targeting SARS-CoV-2, with special attention on ACE2, S protein, Mpro, and PLpro: A review
MOHAMAD ZULKEFLEE SABRI, Joanna Bojarska, Fai‐Chu Wong, et al.
Biocell (2023) Vol. 47, Iss. 8, pp. 1727-1742
Open Access | Times Cited: 1
In silico analysis: Fulleropyrrolidine derivatives against HIV-PR mutants and SARS-CoV-2 Mpro
Noha A. Saleh
Computational and Mathematical Biophysics (2024) Vol. 12, Iss. 1
Open Access
Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study
Sarfraz Ahmad, Muhammad Usman Mirza, John F. Trant
(2023)
Open Access
Page 1

Scroll to top